rcAd002/IAVI R002

A phase 1 randomized, placebo-controlled clinical trial to test the safety and immunogenicity of an oral, replicating Ad26 vectored HIV-1 vaccine in healthy adults

We are looking for healthy men and women ages 18-50 years old for a clinical trial of an experimental HIV vaccine given in capsule form. Note: it is impossible to get HIV infection from the study vaccine.

IPCAVD 010

A phase 1 randomized, placebo-controlled clinical trial to test the safety and immunogenicity of different vaccine schedules of Ad26.Mos.HIV and clade C gp140 in healthy adults

We are looking for healthy men and women ages 18-55 years old for a clinical trial of an experimental HIV vaccine combination given as an intramuscular injection. Note: it is impossible to get HIV infection from the study vaccines.


Interested in one of our studies? Give us a call at (617) 735-4556 or email kstephen@bidmc.harvard.edu.